SUMMARY -Th e aim was to examine whether the postprocedural change in C-reactive protein (CRP) and fi brinogen levels was associated with the extent of periprocedural arterial injury caused by endovascular treatment (EVT). Th e study recruited 71 patients undergoing EVT. Eighty-four patients that underwent angiography served as a control group. CRP and fi brinogen were measured at baseline, and at 8, 24 and 48 hours following the procedure. In all experimental group patients, lesion complexity, percutaneous transluminal angioplasty (PTA) treated segment length, balloon infl ation time and stented segment length were recorded. Th ere was signifi cant increase in plasma CRP and fi brinogen levels 48 hours following EVT (p<0.001). Th ere was no signifi cant diff erence in CRP and fi brinogen levels among diff erent TASC groups. CRP levels were signifi cantly higher in stent subgroup compared to PTA subgroup. Signifi cant positive correlation was found between PTA treated segment length and CRP increase between 8 and 24 hours following EVT (r=0.313, p=0.02), balloon infl ation time and CRP increase in the aforementioned time frame (r=0.270, p=0.03), as well as between CRP increase at 8 hours and stented segment length (r=0.535, p=0.01). Th is study showed that the arterial injury caused by EVT refl ected on the level of infl ammatory biomarkers.
Introduction
Despite recent technical advances that have improved endovascular treatment (EVT) for peripheral arterial disease (PAD), neointimal hyperplasia and subsequent restenosis remain major culprits for failure. Balloon angioplasty leads to atherosclerotic plaque rupture, exposure of its lipid rich core and activation of blood components 1 . Stent implantation causes immediate biological response of protein, fi brinogen and blood cell deposition between stent struts and proliferation of granulation tissue and vascular smooth muscle cells 2 . Th is process of endothelial healing leads to neointimal hyperplasia, which correlates with the extent of arterial wall injury 3 . It has been reported that higher postprocedural levels of infl ammatory biomarkers indicate a higher risk of restenosis 4, 5 . Both C-reactive protein (CRP) and fi brinogen have been established as biomarkers in atherosclerosis, but their exact role remains controversial 6 . Although CRP is mainly synthesized in the liver, it is also produced by vascular smooth muscle cells and macrophages in the atherosclerotic plaque 7, 8 . Plasma concentration of CRP correlates with the level of its synthesis 9 . In vitro studies have shown that mechanical strain leads to local CRP expression in human arteries 10 . Fibrinogen was found to be associated with both the onset and progression of PAD 11, 12 . Apart from being the key determinant of blood viscosity and thrombus formation, fi brinogen is also responsible for neointimal growth by stimulation of vascular smooth muscle cells 13 . Although the correlation between postprocedural levels of infl ammatory biomarkers and EVT has been investigated in several studies, the association with the extent of periprocedural arterial injury has not been completely elucidated.
Th e aim of this study was to examine whether the postprocedural change in CRP and fi brinogen levels 
Subjects and Methods

Study design
Th is observational single-center cohort study was conducted at Department of Diagnostic and Interventional Radiology, Osijek University Hospital Centre, Osijek, Croatia between June 2014 and April 2017. Before enrolment, all patients provided their written informed consent. Th e study was approved by the Ethics Committee of the Osijek University Hospital Centre.
Study population
Patients were referred by vascular surgeon for diagnostic angiography and/or EVT for PAD. Seventyone patients who underwent technically successful PTA with or without stent implantation were recruited. Eighty-four patients who underwent diagnostic angiography of lower limbs during the same period served as a control group. Th eir demographic characteristics are listed in Table 1 . Fontaine classifi cation 14 was used to categorize the severity of PAD. Th e TransAtlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) 15 classifi cation was used to categorize the complexity of lesions to be treated. Patients on hemodialysis treatment, patients with malignant disease, those with a history of surgery, myocardial infarction or coronary endovascular intervention in the past 3 months or endovascular intervention on peripheral arteries in the last 2 weeks, patients on immunosuppressant therapy and those suff ering from or treated for chronic infl ammatory diseases, and patients with clinical or laboratory signs of acute infection (CRP ≥10 mg/L) were excluded from the study. Patients who underwent any other form of EVT besides balloon angioplasty and bare metal stent implantation (such as drug coated balloon angioplasty, drug eluting stent implantation, stent graft implantation, thrombolysis, thrombectomy, etc.) were not included in the study.
Methods
Lower limb arteriography and interventional procedures were performed by an interventional radiologist (T.T., O.R., G.S. or T.M.) using standardized protocol and femoral arterial ipsilateral or contralateral access. Th e procedures were performed on iliac and femoropopliteal arteries according to TASC II guidelines. PTA balloon and stent diameters and length were selected according to the vessel diameter and diseased segment length.
Stenting was performed in case of elastic recoil, fl ow-limiting dissection or residual stenosis greater than 30%. During EVT, all patients received a bolus of 5000 IU of heparin intra-arterially. After EVT, all patients received 40 mg of subcutaneous enoxaparine for three days. In all patients, localization and complexity of the lesion, balloon infl ation time, PTA treated segment length, and stented segment length were recorded.
Clinical data
In all patients, demographic data and medical history were determined using a questionnaire and medical records. Hypertension was defi ned as blood pressure of >130/90 mm Hg or a history of treatment for hypertension. Dyslipidemia was defi ned as a serum high-density lipoprotein (HDL) level <1 mmol/L, low-density lipoprotein (LDL) level >3 mmol/L, cholesterol level >5 mmol/L, and triglyceride level >1.7 mmol/L. Diabetes mellitus was defi ned as having fasting blood glucose level >6.4 mmol/L or hemoglobin A 1c >6% or a history of treatment with antidiabetic medications. Coronary artery disease was defi ned as a history of myocardial infarction, angina pectoris, or coronary revascularization procedures. Cerebrovascular disease was defi ned as a history of transient ischemic attacks, cerebral hemorrhage, stroke, or carotid artery revascularization procedure.
Blood sampling
Baseline peripheral venous blood samples were obtained from each patient before angiography or EVT, in the morning after overnight fast. Subsequently, venous blood samples were obtained at 8 hours, 24 hours and 48 hours after the procedure. CRP levels were measured by an immunoturbidimetric method (Olympus AU480, Beckman Coulter, Tokyo, Japan). Fibrinogen levels were measured by a coagulometric method (BCS XP, Siemens Healthcare Diagnostics, Marburg, Germany). Laboratory values were recorded for each patient and compared between the groups.
Statistical analysis
Data were processed using descriptive statistical methods. Mann-Whitney and Kruskal-Wallis tests were used on sample comparison. Wilcoxon test and Friedman's test were used to detect diff erences between dependent samples. Spearman's rho test was used to determine the association between non-normally distributed variables. Th e level of signifi cance was set at alpha of 0.05. Statistical analysis was performed using MedCalc Statistical Software version 14.12.0 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2014). Th ere was signifi cant increase in both plasma CRP and fi brinogen levels in the fi rst 48 hours following EVT (p<0.001). Th e increase in CRP and fi brinogen levels was also recorded in the control group, but it was not statistically signifi cant. CRP levels were significantly higher in the study group 24 hours following EVT compared to the control group 24 hours following angiography (p<0.05). No other statistically signifi cant diff erence regarding CRP and fi brinogen levels was found between the groups at diff erent time points (Table 2) .
Results
Th
Among patients with diff erent lesion complexity (Table 3) , signifi cant increase in both CRP and fi brinogen levels was noted in patients with lesions classifi ed as TASC II A and B. Patients with TASC II C lesions showed signifi cant increase in CRP (p<0.05), but not in plasma fi brinogen levels (p>0.05). No signifi cant diff erence in CRP and fi brinogen levels was found at examined time points following EVT between diff erent TASC II groups.
Regarding the location of pathology, there was a signifi cant postprocedural increase in plasma CRP and fi brinogen levels (p<0.001) in patients with femoropopliteal interventions and in patients with iliac interventions. However, there was no signifi cant diff erence in postprocedural CRP and fi brinogen elevation between these two subgroups.
Signifi cant increase in CRP (p<0.001) and fi brinogen (p=0.001) levels was found in the subgroup of patients who underwent PTA, as well as in the subgroup that underwent stenting (p<0.001) ( Table 4) . CRP levels were signifi cantly higher (p=0.03) in the stent Mann Whitney U test; CRP = C-reactive protein; EVT = endovascular treatment; PTA = percutaneous transluminal angioplasty time and CRP increase in the aforementioned time frame (r=0.270, p=0.03), as well as between CRP increase in the fi rst 8 hours following stenting and the stented segment length (r=0.535, p=0.01). Th ere was no signifi cant positive correlation between fi brinogen levels and the extent of periprocedural arterial injury.
Discussion
Endovascular treatment as a minimally invasive therapy treats only the diseased vessel segment. However, dilatation with high-pressure balloons and implantation of stents cause periprocedural injury of the arterial wall by endothelial denudation, as well as intimal and medial damage 16 . Th ese injuries are followed by infl ammatory response that often ends with neointimal hyperplasia, a major culprit for long-term EVT failure 17 . Although CRP and fi brinogen are among the most studied infl ammatory biomarkers associated with atherosclerosis, their exact role in the response to arterial injury remains unclear. In the current study, CRP level increase showed positive correlation with PTA treated segment length, balloon infl ation time and stented segment length, suggesting that the extent of periprocedural arterial injury correlates with vascular infl ammatory response. However, we found no such correlation for fi brinogen. Th ese results are consistent with a previous study of coronary arteries 18 , where postprocedural increase of CRP correlated with the total stented segment length. Confl icting results have been reported from the study performed by Wu et al. 19 , where CRP levels were highest 24 hours after percutaneous coronary intervention, but no statistical diff erence regarding infl ammatory response was found between diff erent dilatation pressures and diff erent stented segment lengths. We found no similar studies assessing the increase in infl ammatory biomarkers following EVT on peripheral arteries.
In this study, signifi cant increase was detected in both CRP and fi brinogen levels in patients following EVT. Similar increase in infl ammatory biomarkers was found after EVT in previous studies, both on coronary and peripheral arteries 4, [20] [21] [22] [23] . In the control group, the increase in CRP and fi brinogen levels following angiography was evident, although not statistically signifi cant. Th at mild increase could be attributed to arterial puncture and contrast media application.
On subgroup analysis, both PTA and stent groups showed statistically signifi cant increase in postprocedural CRP and fi brinogen levels. Plasma CRP levels were found to be signifi cantly higher in patients 48 hours following stent implantation compared to PTA group. Th ese results can be correlated with morphometric studies 24, 25 in porcine models where more intimal hyperplasia was found after stenting compared to balloon angioplasty, suggesting a more pronounced infl ammatory response.
Th e TASC II classifi cation, with its latest update in 2015 15 , provides guidelines on optimal treatment modality for PAD based on lesion complexity and location. Although more complex lesions are more diffi cult to treat, requiring more endovascular manipulation, in our study no signifi cant diff erence was found in CRP and fi brinogen levels between diff erent lesion complexity assessed by TASC II classifi cation. Previous studies by Schillinger et al. 20, 22 showed no correlation between postprocedural infl ammatory response and lesion morphology either.
Th e present study showed that the arterial injury caused by EVT refl ected on the level of infl ammatory biomarkers. However, there were several limitations to Although the infl ammatory nature of atherosclerosis is well known for almost two decades 26 , the role of infl ammatory biomarkers has not yet been completely elucidated. Th e present study assessed the correlation between periprocedural arterial injury and infl ammatory response measured by CRP and fi brinogen increase, suggesting that the extent of iatrogenic damage to the arterial wall could relate to future arterial remodeling and subsequent restenosis. Due to the complexity of vascular biology, future studies are warranted to clarify the infl ammatory reactions observed.
